Aclaris Therapeutics, Inc. (LON:0H8T)

Aclaris Therapeutics Revenue

In the year 2024, Aclaris Therapeutics had annual revenue of $18.72M USD, down -40.09%. Aclaris Therapeutics had revenue of $9.21M in the quarter ending December 31, 2024, a decrease of -47.58%.

• Revenue: $18.72M
• Revenue Growth: -40.09%
• P/S Ratio: 6.47
• Revenue / Employee: $292.50K
• Employees: 64
• Market Cap: 96.69M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.72M	-12.53M	-40.09%
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%